NMT sells neuroscience to focus on cardiovascular unit
This article was originally published in Clinica
Executive Summary
NMT Medical has sold all remaining elements of its neuroscience business to Integra LifeSciences Holdings for $5.4m as the company continues its strategy to concentrate on the high-growth cardiovascular sector.